Vapotherm, Inc.

VAPO

$24.18

+147.29% (1 year change)

Avg closing price

Price range

Market Cap

$669 Million

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$35.2 Million

Total revenue in the last quarter.

Net Income

$-8.03 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$-2.09

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

-

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-12.44x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$-6.77 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

284

The number of full time employees.

Revenue & Earnings

Balance Sheet

Vapotherm, Inc.

Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. Its products include Precision Flow, Precision Flow Heliox, Oxygen Assist Module, Nitric Oxidie Disposable Patient Circuit, Tracheostomy Adapter, and Aerogen Adapter. The company was founded by William F. Niland, Jun Cortez, and William Cirksena in 1998 and is headquartered in Exeter, NH.